Christopher Steer

41.5K posts

Christopher Steer banner
Christopher Steer

Christopher Steer

@drcbsteer

A/Prof UNSW. Border Medical Oncology Albury Wodonga Regional Cancer Centre @AWRCCentre PCPA President https://t.co/soCid5JOE5 SIOG, ASCO, COSA, MOGA, MASCC, IGCS

Albury Wodonga Katılım Nisan 2012
3.4K Takip Edilen3.6K Takipçiler
Christopher Steer
Christopher Steer@drcbsteer·
Truly a global effort needed. Well done to @EnriqueSoto8 , @crisbergerot @ASCO and team #gerionc. A major step in the right direction to enable person-centred age friendly cancer care. Adequate assessment yields appropriate care (wherever you live).
Enrique Soto@EnriqueSoto8

Thrilled to share our new ASCO Global Guideline on Geriatric Assessment 🌍👵👴 — supporting cancer care for older adults in resource-constrained settings. Published in @JCOGlobalOncol ➡️ doi.org/10.1200/GO-25-… #gerionc #globonc @ASCO

English
1
2
10
893
Christopher Steer retweetledi
Simon Kuestenmacher
Simon Kuestenmacher@simongerman600·
In just 14 years European countries managed to increase their life expectancy by quite a bit. Really cool visual too!
Simon Kuestenmacher tweet media
English
9
117
473
38.3K
Christopher Steer retweetledi
Caring Futures Cancer Survivorship Program
⭐️ Wonderful to have Prof @WilliamDale_MD at Flinders University today! Huge thank you for his insightful lecture and for joining Profs/Drs. Anna Mislang, Tim To, and Alex Fauer in a fantastic discussion panel. An inspiring session on the global perspective of geriatric oncology!
Caring Futures Cancer Survivorship Program tweet mediaCaring Futures Cancer Survivorship Program tweet mediaCaring Futures Cancer Survivorship Program tweet mediaCaring Futures Cancer Survivorship Program tweet media
English
0
6
8
484
Christopher Steer retweetledi
OncoAlert
OncoAlert@OncoAlert·
Management of immune checkpoint inhibitor-associated toxicities in older adults with cancer: recommendations from the International Society of Geriatric Oncology (SIOG) #CancerHasNoAge 🚨 buff.ly/lg73Tsp Immune checkpoint inhibitors (ICIs) have significantly improved cancer treatment, particularly for older adults, a rapidly growing demographic often prescribed these therapies. However, managing ICI-related toxicities in older adults, especially those with frailty and comorbidities, presents unique challenges. This Policy Review, developed by the International Society of Geriatric Oncology (SIOG), provides an evidence-based framework for healthcare providers, caregivers, and policymakers, addressing specific considerations for older adults that are not sufficiently covered by existing guidelines, while integrating geriatric oncology principles into the treatment approach. #GeriOnc #Immunotherapy @CEochagain @neuendorff_nr @jleipy @martheverhaert @NienkedeGlas @kgsindhu @FabioGomes_Go @Decoster_Lore @SRostoft @nicolobattisti #OncoAlertAF @nataliagandur @acampsmalea @BiagioRicciutMD @yekeduz_emre @HHorinouchi @FadiHaddad_MD @Dr_Ivanoncologo @Abdallah81MD @FernandoOnco @ElisaAgostinett @to_be_elizabeth @bavilima @realbowtiedoc @Erman_Akkus @Lucarecco @GaiaGriguolo @JankovicK Ping GeriOnc Faculty @WilliamDale_MD @IshwariaMD @drcbsteer @ravikanesvaran @crisbergerot
OncoAlert tweet media
English
0
68
171
22.7K